IDOX (IDOX LN) Attractive £5.0m acquisition in Public Sector, strengthens position further | Oxford BioMedica (OXB LN) Interim results; CTL019 approval anticipated by early October | ReNeuron Group (RENE LN) Pipeline continues to progress
17 Aug 2017
N+1 Singer - Morning Song 17-08-2017
Idox plc (IDOX:LON), 65.0 | ReNeuron Group plc (RENE:LON), 3.0 | Oxford BioMedica plc (OXB:LON), 321
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
N+1 Singer - Morning Song 17-08-2017
Idox plc (IDOX:LON), 65.0 | ReNeuron Group plc (RENE:LON), 3.0 | Oxford BioMedica plc (OXB:LON), 321
- Published:
17 Aug 2017 -
Author:
N+1 Singer Team -
Pages:
11
IDOX (IDOX LN) Attractive £5.0m acquisition in Public Sector, strengthens position further | Oxford BioMedica (OXB LN) Interim results; CTL019 approval anticipated by early October | ReNeuron Group (RENE LN) Pipeline continues to progress